COMP <GO>
FRPT vs MZTI // EV/EBITDA & P/E VALUATION
Freshpet Inc. (NASDAQ) VS. The Marzetti Company (NASDAQ) • 15-METRIC TALLY: FRPT 5
— MZTI 7
▲ EV/EBITDA & P/E VALUATION LEADER: MZTI
LAST: $66.12 (+1.63%) • MKT CAP: $3.18B
valuation
38.3x
LAST: $109.12 (+0.66%) • MKT CAP: $2.98B
valuation
10.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FRPT VS. MZTI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FRPT | MZTI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.80% | 23.90% | +16.90 | FRPT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.40% | 20.90% | -14.50 | MZTI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 38.3x | 10.3x | +28.00 | MZTI | /valuation <GO> |
| Free Cash Flow Yield | 5.05% | 6.83% | -1.78 | MZTI | /fcf-yield <GO> |
| Operating Margin | 6.90% | 11.50% | -4.60 | MZTI | /operating-margins <GO> |
| Net Profit Margin | 12.60% | 8.80% | +3.80 | FRPT | /net-margins <GO> |
| Revenue Growth (YoY) | 13.00% | 2.00% | +11.00 | FRPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 3.48% | -3.48 | MZTI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.24 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | FRPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.4 | 61.6 | -3.24 | MZTI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.2x | 16.6x | +2.60 | MZTI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.18B | $2.98B | $199.6M | FRPT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FRPT REV | MZTI REV | FRPT GROSS % | MZTI GROSS % | FRPT FCF | MZTI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.10B | $1.91B | 40.8% | 23.9% | $160.6M | $203.5M |
| FY 2024 | $975.2M | $1.87B | 40.6% | 23.1% | $154.3M | $184.0M |
| FY 2023 | $766.9M | $1.82B | — | — | $75.9M | $225.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FRPT // BETA —
MZTI // BETA —